Top

Reactions Weekly

Published in:

01-08-2023 | Lichen Sclerosus Et Atrophicus | Case report

Fulvestrant/palbociclib

Extragenital lichen sclerosus: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Johnston S, et al. The development of diffuse extragenital lichen sclerosus in a patient on palbociclib and fulvestrant for metastatic breast cancer. British Journal of Dermatology 188 (Suppl. 4): iv90, Jun 2023. Available from: URL: http://doi.org/10.1093/bjd/ljad113.189 [abstract]

Title: Fulvestrant/palbociclib
Extragenital lichen sclerosus: case report
Publication date: 01-08-2023
Publisher: Springer International Publishing
Keywords: Lichen Sclerosus Et Atrophicus
Hypopigmentation
Skin Wrinkling
Denosumab
Breast Cancer
Breast Cancer
Atopic Dermatitis
Fulvestrant
Denosumab
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-44981-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Fulvestrant/palbociclib

Extragenital lichen sclerosus: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Ipilimumab/nivolumab

Citalopram

Immunosuppressants

Dasatinib/eltrombopag/imatinib

Dapagliflozin

Camrelizumab